C. Baker

发表

Evaluation of Alamar colorimetric MIC method for antimicrobial susceptibility testing of gram-negative bacteria

F. Tenover, S. Banerjee, C. Baker, 1994, Journal of clinical microbiology.

Effect of Temperature on the In Vitro Susceptibility of Staphylococcus aureus to Penicillinase-Resistant Penicillins

C. Baker, C. Thornsberry, J. Caruthers, 1973, Antimicrobial Agents and Chemotherapy.

Evaluation of commercial methods for determining antimicrobial susceptibility of Streptococcus pneumoniae

F. Tenover, C. Baker, J. Swenson, 1996, Journal of clinical microbiology.

Evaluation of Alamar colorimetric broth microdilution susceptibility testing method for staphylococci and enterococci

F. Tenover, C. Baker, C. N. Baker, 1996, Journal of clinical microbiology.

Antimicrobial susceptibility testing of Francisella tularensis with a modified Mueller-Hinton broth

D. Hollis, C. Baker, C. Thornsberry, 1985, Journal of clinical microbiology.

Optimizing testing of methicillin-resistant Staphylococcus species.

F. Tenover, C. Baker, M. Huang, 1994, Diagnostic microbiology and infectious disease.

InVitro Susceptibilities ofAerotolerant Campylobacter Isolates to22Antimicrobial Agents

C. Baker, 1992 .

In vitro susceptibilities of aerotolerant Campylobacter isolates to 22 antimicrobial agents

I. Wachsmuth, J. Kiehlbauch, C. Baker, 1992, Antimicrobial Agents and Chemotherapy.

Halophilic Vibrio species isolated from blood cultures

D. Hollis, R. Weaver, C. Baker, 1976, Journal of clinical microbiology.

Methods for determining susceptibility of fastidious and unusual pathogens to selected antimicrobial agents.

L. Mcdougal, C. Baker, C. Thornsberry, 1988, Diagnostic microbiology and infectious disease.

Susceptibility testing of fastidious and unusual pathogens

L. Mcdougal, C. Baker, C. Thornsberry, 1987 .

Campylobacter butzleri sp. nov. isolated from humans and animals with diarrheal illness

A. Steigerwalt, Nicholson, I. Wachsmuth, 1991, Journal of clinical microbiology.

Infection caused by Francisella philomiragia (formerly Yersinia philomiragia). A newly recognized human pathogen.

C. Broome, D. J. Brenner, J. Wenger, 1989, Annals of internal medicine.

Antibiotic Susceptibility of Streptococcus bovis and Other Group D Streptococci Causing Endocarditis

R. Facklam, C. Baker, C. Thornsberry, 1974, Antimicrobial Agents and Chemotherapy.

Antimicrobial Susceptibility of Streptococcus mutans Isolated from Patients with Endocarditis

C. Baker, C. Thornsberry, Clyde Thornsberry, 1974, Antimicrobial Agents and Chemotherapy.

Human disease associated with "Campylobacter upsaliensis" (catalase-negative or weakly positive Campylobacter species) in the United States

T. Barrett, D. J. Brenner, D. Perlman, 1989, Journal of clinical microbiology.

In Vitro Activity of Antimicrobial Agents on Legionnaires Disease Bacterium

C. Baker, C. Thornsberry, L. A. Kirven, 1978, Antimicrobial Agents and Chemotherapy.

Campylobacter hyointestinalis associated with human gastrointestinal disease in the United States

G. Schmid, T. Barrett, D. J. Brenner, 1987, Journal of clinical microbiology.

Prevalence of Neisseria meningitidis relatively resistant to penicillin in the United States, 1991. Meningococcal Disease Study Group.

F. Tenover, B. Plikaytis, M. Reeves, 1994, The Journal of infectious diseases.

Meningococcal Disease in the United States—1986

R. Pinner, C. Broome, C. Frasch, 1991 .

Synergism, killing kinetics, and antimicrobial susceptibility of group A and B streptococci

R. Facklam, C. Baker, C. Thornsberry, 1981, Antimicrobial Agents and Chemotherapy.

Phenotypic characteristics, fatty acid composition, and isoprenoid quinone content of CDC group IIg bacteria

C. W. Moss, D. Hollis, M. Daneshvar, 1995, Journal of clinical microbiology.

Meningococcal disease in the United States--1986. Meningococcal Disease Study Group.

R. Pinner, C. Broome, C. Frasch, 1991, The Journal of infectious diseases.

"Upper limits of normal" antistreptolysin O and antideoxyribonuclease B titers.

C. Baker, G. C. Klein, W. L. Jones, 1971, Applied microbiology.

Accuracy of the E test for determining antimicrobial susceptibilities of staphylococci, enterococci, Campylobacter jejuni, and gram-negative bacteria resistant to antimicrobial agents

F. Tenover, S. Banerjee, C. Baker, 1992, Journal of clinical microbiology.

Development of provisional disc diffusion breakpoints for testing quinupristin/dalfopristin.

F. Tenover, C. Baker, 1997, The Journal of antimicrobial chemotherapy.

Antibacterial activity of fortimicin A compared with those of five other aminoglycosides, and factors affecting susceptibility tests

R. Jones, A. Barry, C. Baker, 1981, Antimicrobial Agents and Chemotherapy.

Inoculum standardization in antimicrobial susceptibility testing: evaluation of overnight agar cultures and the Rapid Inoculum Standardization System

C. Baker, C. Thornsberry, R. Hawkinson, 1983, Journal of clinical microbiology.

Characterization and identification of 95 diphtheroid (group JK) cultures isolated from clinical specimens

D. Hollis, R. Weaver, C. Baker, 1979, Journal of clinical microbiology.

Effect of Calcium and Magnesium Ions on the Susceptibility of Pseudomonas Species to Tetracycline, Gentamicin Polymyxin B, and Carbenicillin

C. Baker, C. Thornsberry, R. D'amato, 1975, Antimicrobial Agents and Chemotherapy.

Medium-dependent zone size discrepancies associated with susceptibility testing of group D streptococci against various cephalosporins

R. Jones, D. Sahm, C. Baker, 1983, Journal of clinical microbiology.

Antimicrobial susceptibility testing systems past and present: A documented overview. Part II

M. Gradus, C. Baker, C. Thornsberry, 1985 .

Influence of growth medium on the in vitro activities of second- and third-generation cephalosporins against Streptococcus faecalis

R. Jones, D. Sahm, C. Baker, 1984, Journal of clinical microbiology.

In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains

R. Jones, C. Baker, C. Thornsberry, 1980, Antimicrobial Agents and Chemotherapy.

Disk Diffusion Susceptibility Test Troubleshooting Guide

J. Miller, C. Baker, C. Thornsberry, 1984 .

Cefoperazone: evaluation of the in vitro activity and an analysis of the disk diffusion test.

R. Jones, A. Barry, C. Baker, 1980, Clinical therapeutics.

Antimicrobial Susceptibility Testing of Cefoperazone

Ronald N. Jones, A. Barry, C. Baker, 2003 .

Tentative interpretive standards for agar disk diffusion antimicrobial susceptibility testing of cefoperazone

R. Jones, A. Barry, C. Baker, 1982, Journal of clinical microbiology.

Comparison of the E Test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria

C Thornsberry, D. Culver, D H Culver, 1991, Journal of clinical microbiology.

Evaluation of the MicroScan antimicrobial susceptibility system with the autoSCAN-4 automated reader

D. Rhoden, C. Baker, C. Thornsberry, 1986, Journal of clinical microbiology.

Two percent sodium chloride is required for susceptibility testing of staphylococci with oxacillin when using agar-based dilution methods

F. Tenover, S. Banerjee, C. Baker, 1993, Journal of clinical microbiology.

Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin

R. Jones, A. Barry, C. Baker, 1980, Antimicrobial Agents and Chemotherapy.

Compound A49759, the 3-O-demethyl derivative of fortimicin A: in vitro comparison with six other aminoglycoside antibiotics

R. Jones, A. Barry, C. Baker, 1980, Antimicrobial Agents and Chemotherapy.

The E-Test and Campylobacter jejuni.

C. Baker, 1992, Diagnostic microbiology and infectious disease.

Tentative criteria for confirming the in vitro susceptibilities of Haemophilus influenzae and Neisseria gonorrhoeae to two fluoroquinolones (sparfloxacin and levofloxacin), including quality control parameters

P. Murray, F. Tenover, J. Jorgensen, 1993, Journal of clinical microbiology.

Proposed interpretive criteria and quality control parameters for ofloxacin susceptibility testing of Neisseria gonorrhoeae

P. Murray, J. Washington, A. Barry, 1992, Journal of clinical microbiology.

Relationship between in vitro susceptibility test results for chloramphenicol and production of chloramphenicol acetyltransferase by Haemophilus influenzae, Streptococcus pneumoniae, and Aerococcus species

C. Baker, C. Thornsberry, H. Matthews, 1988, Journal of clinical microbiology.

Micro antistreptolysin O test.

C. Baker, M. Moody, G. C. Klein, 1968, Applied microbiology.

A Simplified Method for Testing Bordetella pertussisfor Resistance to Erythromycin and Other Antimicrobial Agents

F. Tenover, C. Baker, B. Hill, 2000, Journal of Clinical Microbiology.

Piperacillin (T-1220), a new semisynthetic penicillin. II. In vitro antimicrobial activity and synergy comparison with carbenicillin and gentamicin.

R. Jones, A. Barry, C. Baker, 1979, The Journal of antibiotics.

Genotypic and phenotypic characterization of Helicobacter cinaedi and Helicobacter fennelliae strains isolated from humans and animals

A. Steigerwalt, I. Wachsmuth, D. N. Cameron, 1995, Journal of clinical microbiology.

Genotypic and Phenotypic Characterization ofHelicobacter cinaediand Helicobacter fennelliaeStrains Isolated from Humans and Animals

A. Steigerwalt, K. Wachsmuth, D. N. Cameron, 1995 .

Proposed interpretive criteria and quality control parameters for testing in vitro susceptibility of Neisseria gonorrhoeae to ciprofloxacin

P. Murray, J. Washington, A. Barry, 1991, Journal of clinical microbiology.

In vitro antimicrobial activity of piperacillin and seven other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase producing strains.

R. Jones, C. Baker, C. Thornsberry, 1979, The Journal of antimicrobial chemotherapy.

Proposed interpretive criteria and quality control parameters for testing susceptibility of Neisseria gonorrhoeae to beta-lactam-clavulanate combinations

P. Murray, J. Washington, A. Barry, 1992, Journal of clinical microbiology.

Inhibition of β-Lactamase in Neisseria gonorrhoeae by Sodium Clavulanate

J. Miller, C. Baker, C. Thornsberry, 1978, Antimicrobial Agents and Chemotherapy.

Inhibition of beta-lactamase in Neisseria gonorrhoeae by sodium clavulanate.

J. Miller, C. Baker, C. Thornsberry, 1978, Antimicrobial agents and chemotherapy.

Piperacillin susceptibility tests by the single-disk agar diffusion technique

R. Jones, A. Barry, C. Baker, 1979, Antimicrobial Agents and Chemotherapy.

Haemophilus test medium (HTM) susceptibility methods: Results of evaluations of reproducibility, stability, and medium quality

Ronald N. Jones, G. Doern, J. Hindler, 1993 .

autoSCAN-4 System for Identification of Gram-Negative Bacilli

D. Rhoden, B. Schable, P. Smith, 1986, Journal of clinical microbiology.

Micro test for streptococcal anti-deoxyribonuclease B.

C. Baker, M. Moody, G. C. Klein, 1969, Applied microbiology.

Comparison of antistreptolysin O latex screening test with the antistreptolysin O hemolytic test.

C. Baker, M. Moody, G. C. Klein, 1970, Applied microbiology.

Restriction fragment length polymorphisms in the ribosomal genes for species identification and subtyping of aerotolerant Campylobacter species

B. Swaminathan, B. Plikaytis, I. Wachsmuth, 1991, Journal of clinical microbiology.